These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinical aspect of recent progress in phosphate metabolism. Hyperphosphatemia and hypophosphatemia]. Michigami T Clin Calcium; 2009 Jun; 19(6):785-92. PubMed ID: 19483272 [TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
4. Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease. Stubbs J; Liu S; Quarles LD Semin Dial; 2007; 20(4):302-8. PubMed ID: 17635819 [TBL] [Abstract][Full Text] [Related]
5. Hypophosphatemia: an evidence-based problem-solving approach to clinical cases. Assadi F Iran J Kidney Dis; 2010 Jul; 4(3):195-201. PubMed ID: 20622306 [TBL] [Abstract][Full Text] [Related]
6. Hyperparathyroidism. Tonini G; Tatò L; Rigon F; Radetti G; De Sanctis C; De Sanctis V; Buzi F; Bozzola M; Bona G; Bernasconi S Minerva Pediatr; 2004 Feb; 56(1):125-31. PubMed ID: 15249924 [TBL] [Abstract][Full Text] [Related]
7. Metabolic bone disease secondary to renal and intestinal disorders. Muldowney FP Calif Med; 1969 May; 110(5):397-409. PubMed ID: 4890532 [TBL] [Abstract][Full Text] [Related]
8. Hypophosphatemia induced by intravenous administration of saccharated ferric oxide: another form of FGF23-related hypophosphatemia. Shimizu Y; Tada Y; Yamauchi M; Okamoto T; Suzuki H; Ito N; Fukumoto S; Sugimoto T; Fujita T Bone; 2009 Oct; 45(4):814-6. PubMed ID: 19555782 [TBL] [Abstract][Full Text] [Related]
9. Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement. Endo I; Fukumoto S; Ozono K; Namba N; Tanaka H; Inoue D; Minagawa M; Sugimoto T; Yamauchi M; Michigami T; Matsumoto T Bone; 2008 Jun; 42(6):1235-9. PubMed ID: 18396126 [TBL] [Abstract][Full Text] [Related]
14. Emerging topics in pediatric bone and mineral disorders 2008. McKay CP; Portale A Semin Nephrol; 2009 Jul; 29(4):370-8. PubMed ID: 19615558 [TBL] [Abstract][Full Text] [Related]
15. [Hypophosphatemia. A review (author's transl)]. Sibille M Anesth Analg (Paris); 1979; 36(7-8):289-300. PubMed ID: 118683 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of vitamin D status of llamas and alpacas with hypophosphatemic rickets. Van Saun RJ; Smith BB; Watrous BJ J Am Vet Med Assoc; 1996 Sep; 209(6):1128-33. PubMed ID: 8800263 [TBL] [Abstract][Full Text] [Related]
17. [Altered calcium-phosphorus metabolism and low-protein diet]. Santoro D; Cianciaruso B G Ital Nefrol; 2008; 25 Suppl 42():S25-8. PubMed ID: 18828130 [TBL] [Abstract][Full Text] [Related]
18. Solomon's epidermal nevus syndrome (type: linear nevus sebaceus) and hypophosphatemic vitamin D-resistant rickets. Oranje AP; Przyrembel H; Meradji M; Loonen MC; de Klerk JB Arch Dermatol; 1994 Sep; 130(9):1167-71. PubMed ID: 8085871 [TBL] [Abstract][Full Text] [Related]
19. Clinical disorders of phosphorus metabolism. Yu GC; Lee DB West J Med; 1987 Nov; 147(5):569-76. PubMed ID: 3321712 [TBL] [Abstract][Full Text] [Related]
20. [Regulation of phosphatemia and hypophosphatemia]. Essig M; Friedlander G Rev Prat; 1998 Jun; 48(11):1218-25. PubMed ID: 9781175 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]